MetLife Investment Management’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Buy |
27,511
+5,113
| +23% | +$33.8K | ﹤0.01% | 2243 |
|
|
2025
Q1 | $205K | Sell |
22,398
-583
| -3% | -$5.33K | ﹤0.01% | 2188 |
|
|
2024
Q4 | $241K | Hold |
22,981
| – | – | ﹤0.01% | 2207 |
|
|
2024
Q3 | $275K | Buy |
22,981
+12,949
| +129% | +$155K | ﹤0.01% | 2123 |
|
|
2024
Q2 | $57.7K | Buy |
+10,032
| New | +$57.7K | ﹤0.01% | 2736 |
|
|
2022
Q4 | – | Sell |
-18,975
| Closed | -$133K | – | 2832 |
|
|
2022
Q3 | $133K | Hold |
18,975
| – | – | ﹤0.01% | 2539 |
|
|
2022
Q2 | $129K | Hold |
18,975
| – | – | ﹤0.01% | 2590 |
|
|
2022
Q1 | $268K | Buy |
18,975
+6,917
| +57% | +$97.5K | ﹤0.01% | 2168 |
|
|
2021
Q4 | $175K | Buy |
+12,058
| New | +$175K | ﹤0.01% | 2139 |
|